These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 3149933)

  • 1. Antisecretory effect of a PGE2 derivative, enprostil (TA/RS-84135): inhibitory action of amogastrin-stimulated secretion.
    Kohli Y; Katoh T; Suzuki K
    Drugs Exp Clin Res; 1988; 14(11):673-8. PubMed ID: 3149933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gastric antisecretory and antiulcer properties of enprostil, (+/-)-11 alpha, 15 alpha-dihydroxy-16-phenoxy-17,18,19,20-tetranor-9-oxoprosta- 4,5,13(t)-trienoic acid methyl ester.
    Roszkowski AP; Garay GL; Baker S; Schuler M; Carter H
    J Pharmacol Exp Ther; 1986 Nov; 239(2):382-9. PubMed ID: 3095537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitory action of enprostil (4,5-dehydro-16-phenoxy-17,18,19,20-tetranor-PGE2) on tetra-gastrin stimulated acid secretion in human subjects.
    Moriga M; Aono M; Narusawa H; Kohli Y; Kato T; Kajiyama G; Inoue M; Miyoshi A
    Gastroenterol Jpn; 1989 Apr; 24(2):115-9. PubMed ID: 2501133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of trimoprostil on gastric secretion in man.
    Ishimori A; Kawamura T; Koizumi F
    Arzneimittelforschung; 1988 Jun; 38(6):833-9. PubMed ID: 3140824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effects of enprostil on changes in the gastric transepithelial potential differential induced by aspirin].
    Florent C; Desaint B; Joubert M; Maurel M; Bernier JJ
    Gastroenterol Clin Biol; 1987 Dec; 11(12):886-90. PubMed ID: 3130280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of a single oral dose of enprostil on gastric secretion and gastrin release. Studies in healthy volunteers and patients with pernicious anemia.
    Buchanan N; Laferla G; Hearns J; Buchanan KD; Crean GP; McColl KE
    Am J Med; 1986 Aug; 81(2A):40-3. PubMed ID: 3092653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of the natural and unnatural isomers and degradation products of enprostil on gastric acid secretion and gastrointestinal motility in the rat.
    Rosenkranz RP; Fisher PE; Turke ML; Perry MR; Wong AG; Wren DL; Cooper GF; Smith WL
    Arzneimittelforschung; 1989 Dec; 39(12):1568-71. PubMed ID: 2516443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enprostil, a synthetic prostaglandin E2 analogue, inhibits meal-stimulated gastric acid secretion and gastrin release in patients with duodenal ulcer.
    Thomas FJ; Koss MA; Hogan DL; Isenberg JI
    Am J Med; 1986 Aug; 81(2A):44-9. PubMed ID: 3092654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sustained enhancement of gastric HCO3 secretion in humans by enprostil.
    Guslandi M; Tittobello A
    Therapie; 1991; 46(1):13-5. PubMed ID: 1902327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specificity of PGE2 analogs interaction between food intake and antisecretory effect.
    Levine RA; Petokas S; Czarny L; Schwartz GJ; Bynum L
    Prostaglandins Leukot Med; 1986 Oct; 24(2-3):219-25. PubMed ID: 3099313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Synthetic analog of prostaglandin E2 (enprostil) in the treatment of peptic ulcer].
    Grigor'ev PIa; Isakov VA
    Sov Med; 1991; (3):39-43. PubMed ID: 1909055
    [No Abstract]   [Full Text] [Related]  

  • 12. Central and peripheral effects of prostaglandin E2 and enprostil on gastric acid secretion in the rat.
    Sautereau D; Chicau-Chovet M; Tsocas A; Rozé C
    Eur J Pharmacol; 1991 Mar; 195(2):217-24. PubMed ID: 1678708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enprostil reduces the increase of gastric corpus mucosal mass induced by the hydrogen-potassium-stimulated adenosine triphosphatase inhibitor BY 831-78 in the rat.
    Inauen W; Rohner C; Koelz HR; Herdmann J; Schürer-Maly CC; Varga L; Halter F
    Gastroenterology; 1989 Oct; 97(4):846-52. PubMed ID: 2570729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of the synthetic prostanoid Ro 22-6923 on gastric secretion and blood flow in Heidenhain pouch dogs.
    Gaginella TS; Bertko RJ; Müller RK; Gallo-Torres H; Sullivan AC
    J Pharmacol Exp Ther; 1985 Jan; 232(1):208-13. PubMed ID: 3917506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stimulatory effect of enprostil, an anti-ulcer prostaglandin, on gastric mucus secretion.
    Waterbury LD; Mahoney JM; Peak TM; Cohn RG; Garay GL
    Am J Med; 1986 Aug; 81(2A):30-3. PubMed ID: 3092651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of misoprostol on gastric pepsin secretion and human mucosal cell loss in man.
    Quadros E; Wilson DE
    J Assoc Acad Minor Phys; 1990; 1(2):17-9. PubMed ID: 2135692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The gastric antisecretory profile of enprostil.
    Wong AG; Turke ML; Perry MR; Blissard DD; Waterbury LD; Smith WL
    Proc West Pharmacol Soc; 1989; 32():49-56. PubMed ID: 2506551
    [No Abstract]   [Full Text] [Related]  

  • 18. Inhibition of gastric secretion in man by rioprostil, a new synthetic methyl prostaglandin E1.
    Demol P; Wingender W; Weihrauch TR; Graefe KH
    Arzneimittelforschung; 1985; 35(5):861-3. PubMed ID: 3927929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stimulation of HCO3- secretion by the prostaglandin E2 analog enprostil: studies in human stomach and rat duodenum.
    Heylings JR; Feldman M
    Prostaglandins; 1986 Dec; 32(6):907-17. PubMed ID: 3104991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antisecretory and serum gastrin lowering effect of enprostil in patients with duodenal ulcer disease.
    Mahachai V; Walker K; Sevelius H; Thomson AB
    Gastroenterology; 1985 Sep; 89(3):555-61. PubMed ID: 3926591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.